Mohammed et al. [13] demonstrated that Gal-3 serves as a valuable indicator of progressive ventricular remodeling in pediatric patients with congenital heart disease (CHD), showing a positive correlation with pulmonary artery pressure as well as left atrial and ventricular diameters [14]. Here, LGALS3 is linked to congenital heart disease.